Matisse Capital’s BlackRock Health Sciences Term Trust BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-51,296
Closed -$751K – 194
2023
Q4
$751K Hold
51,296
– – 0.4% 86
2023
Q3
$739K Sell
51,296
-30,604
-37% -$477K 0.52% 71
2023
Q2
$1.34M Sell
81,900
-100
-0.1% -$1.63K 0.83% 31
2023
Q1
$1.37M Hold
82,000
– – 0.88% 27
2022
Q4
$1.27M Hold
82,000
– – 1.12% 30
2022
Q3
$1.22M Hold
82,000
– – 1.55% 25
2022
Q2
$1.35M Buy
+82,000
New +$1.41M 1.28% 19
2021
Q3
– Sell
-107,000
Closed -$3.09M – 153
2021
Q2
$3.09M Sell
107,000
-18,000
-14% -$498K 0.98% 34
2021
Q1
$3.29M Buy
+125,000
New +$3.55M 0.95% 40

Other funds holding BMEZ

Matisse Capital's BMEZ Position: Q1 2024 in Review

Matisse Capital sold out of BlackRock Health Sciences Term Trust (BMEZ) in Q1 2024, closing a stake of 51,296 shares — an estimated $751K sold.

Matisse Capital first reported a position in BMEZ in Q1 2021 and held it in 9 quarters. The position peaked at $3.29M in Q1 2021. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Matisse Capital reported no remaining BlackRock Health Sciences Term Trust position as of Q1 2024 after selling out during the quarter.
  • Matisse Capital sold 51,296 BlackRock Health Sciences Term Trust shares in Q1 2024, an estimated $751K.
  • Matisse Capital first reported a position in BlackRock Health Sciences Term Trust in Q1 2021 and held it in 9 quarters.
  • Matisse Capital's BlackRock Health Sciences Term Trust position peaked at $3.29M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Term Trust as of Q1 2024.

Based on Matisse Capital's 13F filing for Q1 2024, filed 30 Apr 2024.